The recommended oral dose of Intelence tablets is 200 mg (one 200mg tablet or two 100mg tablets) taken twice daily after a meal.
This new 200mg product formulation is expected to launch in the US later this month, while the 100 mg tablet will remain available.
Intelence received FDA approval November 2009, and is currently marketed in the US by Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, LP.